Bioniche Life Sciences Inc. is a leading, fully-integrated biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.
The information contained in the Company’s news releases was accurate at the time of posting on this website, but the information may be superseded by subsequent corporate disclosures.
For recent media coverage of Bioniche Life Sciences Inc. click here >>
December 2, 2013
Bioniche Life Sciences Inc. Horse Product Approved for Sale in the U.S.
November 7, 2013
Bioniche Life Sciences Inc. Reports Fiscal 2014 First Quarter Results
November 4, 2013
Bioniche Life Sciences Inc. Announces the Appointment of a New Chief Executive Officer
Bioniche Key Facts
President & CEO:
TSX stock symbol:
vaccines, replacement of antibiotics
One Health: E. coli O157 vaccine, other veterinary biopharmaceutical products to address diseases in livestock which may have an effect on human health